Takeo Kurihashi

Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial

Masato Yoneda, Yasushi Honda, Yuji Ogawa et al. · BMJ Open Diabetes Research & Care · 2021 · 98 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial

Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu et al. · Clinical and Translational Gastroenterology · 2022 · 30 citations · Full text

Dentistry, Periodontics, Periodontology +17

A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease

Satsuki Sato, Yohei Kamata, Takaomi Kessoku et al. · Scientific Reports · 2022 · 23 citations · Full text

Dentistry, Periodontics, Periodontal Medicine +16

Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial

Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu et al. · Trials · 2020 · 22 citations · Full text

Dentistry, Periodontics, Periodontology +17

Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study)

Anna Ozaki, Masato Yoneda, Takaomi Kessoku et al. · Contemporary Clinical Trials Communications · 2019 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11